Techne's Q3 2025 earnings call, including 6% organic growth, FDA-driven opportunities, and strategies to tackle NIH funding & ...

Sartorius Stedim Biotech, a subsidiary of Sartorius AG, is a leading provider of bioprocessing equipment and consumables. It offers a comprehensive portfolio that spans the full spectrum of upstream ...

MassBio’s new report outlines several concerns, including NIH cuts undermining the research engine, FDA reductions delaying ...

Sierra Leone’s President Julius Maada Bio Receives Annual Public Procurement Compliance Reports, Urges Digital Reforms to ...

Positive Phase 1 data from lead program, SENTI-202, recently presented at the AACR Annual Meeting: SENTI-202 was generally well tolerated, preliminary RP2D identified; 4 of 7 pati ...

Private Equity focused on investment and operations within the Life Science industry faces significant compliance, operational and business risk ...

bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird" or "the Company"), Carlyle (NASDAQ: CG) ("Carlyle"), SK Capital Partners, LP ("SK Capital") and Beacon Parent Holdings, L.P. ("Parent") announced today ...

Five energy companies in New Mexico have been awarded $3.3 million through the Advanced Energy Award Pilot Program, according ...

We think the stake in wide-moat Sartorius contributes to Bio-Rad’s moat. Although Bio-Rad does not have a controlling stake, Sartorius accounts for approximately 40% of Bio-Rad’s fair value in our ...

Brian Lortie, president and CEO at Uniquity Bio, offered up key insights on building teams, securing capital, and operating with efficiency during a recent Business of Biotech podcast recording.